NPPA revise prices of Drugs: The government-controlled National Pharmaceutical Pricing Authority (NPPA), which monitors drug prices, has announced the retail price of 65 new drug formulations. Also, maximum prices of medicines having 13 formulations have been fixed. Further, the ceiling prices of seven other medicines were revised to include the impact of 0.00551 per cent increase in drug prices in the National List of Essential Medicines (NLEM) based on changes in the Wholesale Price Index (WPI) for 2024. Went.
Changes made in the prices of medicines
In the 128th meeting of NPPA held on December 12, the decision regarding revision of formulation prices was taken. NPPA has fixed prices for medicines for type 2 diabetes, high cholesterol, bacterial infections and painkillers, while other medicines whose prices have been increased include vaccines for rabies, tetanus and measles.
Revision in retail price of FDC category medicines
Determining the prices of medicines or changing or revising them is a regular function of NPPA. NPPA works to revise and enforce the prices of drugs and formulas in the country. Their objective is to stop pharmaceutical companies from charging higher prices from consumers.
NPPA monitors the prices of both controlled and deregulated drugs. In a recent government notification, the retail prices of essential fixed dose combination drugs (FDCs) such as the combination of atorvastatin and ezetimibe tablets, which are used to treat high cholesterol by reducing cholesterol (LDL) and triglyceride levels, have been fixed. Is done to treat.
These are also included in the list
Fixed dose combinations (FDC) are medicines in which more than one medicine is combined in a single pill. The list also includes the combination of dispersible amoxicillin and potassium clavulanate in the FDC category and the combination of gliclazide and metformin hydrochloride, which are used to treat bacterial infections like sinusitis and type-2 diabetes, respectively. NPPA has also fixed the retail prices of several dietary supplements, which include oral cholecalciferol (vitamin D3) tablets and antifungal itraconazole capsules.
The 20 drugs whose maximum prices have been revised include 13 new drugs such as injectable immunoglobulin for rabies, tetanus, measles and BCG, while the prices of seven other drugs have been revised to include the impact of wholesale rate (WPI). Modifications have been made, including injectable versions of thiamine (vitamin B1), versions of lignocaine (local anesthetic), ascorbic acid (vitamin C). Tablets and clarithromycin (antibiotic) tablets and liquid versions.
Also read:
Amazing jump in the export of leather sector of the country, huge demand coming from America and Europe.
